Cite
Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM Trial.
MLA
Rhee, Tae-Min, et al. “Aspirin vs Clopidogrel for Long-Term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM Trial.” JAMA Cardiology, vol. 8, no. 6, June 2023, pp. 535–44. EBSCOhost, https://doi.org/10.1001/jamacardio.2023.0592.
APA
Rhee, T.-M., Bae, J.-W., Park, K. W., Rha, S.-W., Kang, J., Lee, H., Yang, H.-M., Kwak, S.-H., Chae, I.-H., Shin, W.-Y., Kim, D.-K., Oh, J. H., Jeong, M. H., Kim, Y. H., Lee, N. H., Hur, S.-H., Yoon, J., Han, J.-K., Shin, E.-S., … Kim, H.-S. (2023). Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM Trial. JAMA Cardiology, 8(6), 535–544. https://doi.org/10.1001/jamacardio.2023.0592
Chicago
Rhee, Tae-Min, Jang-Whan Bae, Kyung Woo Park, Seung-Woon Rha, Jeehoon Kang, Heesun Lee, Han-Mo Yang, et al. 2023. “Aspirin vs Clopidogrel for Long-Term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM Trial.” JAMA Cardiology 8 (6): 535–44. doi:10.1001/jamacardio.2023.0592.